Melanoma immunotherapy using mature DCs expressing the constitutive proteasome-Reference-Cited by-同舟云学术

Melanoma immunotherapy using mature DCs expressing the constitutive proteasome

Published:2013-06-24 Issue:7 Volume:123 Page:3135-3145
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Dannull Jens,Haley N. Rebecca,Archer Gary,Nair Smita,Boczkowski David,Harper Mark,De Rosa Nicole,Pickett Nancy,Mosca Paul J.,Burchette James,Selim Maria A.,Mitchell Duane A.,Sampson John,Tyler Douglas S.,Pruitt Scott K.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference29 articles.

1. Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII

2. Replacement of proteasome subunits X and Y by LMP7 and LMP2 induced by interferon-γ for acquirement of the functional diversity responsible for antigen processing

3. Tumor Cell Lines Expressing the Proteasome Subunit Isoform LMP7E1 Exhibit Immunoproteasome Deficiency

4. Cancer immunotherapy via dendritic cells

5. Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smart Physicochemical-triggered Chitosan-based Nanogels for siRNA Delivery and Gene Therapy: A Focus on Emerging Strategies and Paradigms for Cancer Therapy;Current Medicinal Chemistry;2024-06-05

2. Cancer mRNA vaccines: clinical advances and future opportunities;Nature Reviews Clinical Oncology;2024-05-17

3. RNA therapeutics in cancer treatment;Progress in Molecular Biology and Translational Science;2024

4. A Comprehensive Review of Small Interfering RNAs (siRNAs): Mechanism, Therapeutic Targets, and Delivery Strategies for Cancer Therapy;International Journal of Nanomedicine;2023-12

5. Current Developments and Challenges of mRNA Vaccines;Annual Review of Biomedical Engineering;2022-06-06